| Autor: |
Varma, Suraj K, Horton, Ari E, Taylor, Anna L, Ditchfield, Michael R, Hope, Sarah A, Rao, Srinidhi JV |
| Předmět: |
|
| Zdroj: |
Medical Journal of Australia; Sep2022, Vol. 217 Issue 5, p260-261, 2p |
| Abstrakt: |
Keywords: COVID-19; Magnetic resonance imaging; Echocardiography; Vaccination; Cardiac imaging techniques EN COVID-19 Magnetic resonance imaging Echocardiography Vaccination Cardiac imaging techniques 260 261 2 09/29/22 20220905 NES 220905 Myocarditis in adolescents and young adults following the administration of coronavirus disease 2019 (COVID-19) mRNA vaccines has been reported.1 Vaccination of 12-16-year-old adolescents with Comirnaty (tozinameran, Pfizer-BioNTech) and Spikevax (elasomeran, Moderna) was approved in Australia on 22 July 2021 and 3 September 2021 respectively.2 In this report, we describe the initial diagnosis, imaging findings, and short term outcomes for adolescents who presented with COVID-19 vaccine-associated myocarditis to the Monash Children's Hospital, a tertiary centre in Melbourne with a paediatric cardiology service. Myocarditis was defined by standard criteria.3 All patients underwent electrocardiography (ECG), echocardiography, and cardiac magnetic resonance (CMR) imaging. Magnetic resonance imaging, Echocardiography, Vaccination, COVID-19, Cardiac imaging techniques. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text